| Description | Tetracaine is a topical local anesthetic for the eyes; works by interfering with entry of sodium ions into nerve cells. |
|---|
| Related Catalog | Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Research Areas >> Neurological Disease |
|---|
| Solvent | In Vitro: DMSO : ≥ 43 mg/mL (162.66 mM) * "≥" means soluble, but saturation unknown. |
|---|
| Solubility | 1 mM3.7827 mL18.9136 mL37.8272 mL5 mM0.7565 mL3.7827 mL7.5654 mL10 mM0.3783 mL1.8914 mL3.7827 mL |
|---|
| Storage | Powder-20°C3 years 4°C2 yearsIn solvent-80°C6 months -20°C1 month |
|---|
| Shipping | Room temperature in continental US; may vary elsewhere |
|---|
| SMILES | O=C(OCCN(C)C)C1=CC=C(NCCCC)C=C1 |
|---|
| Related Molecules | EIPA | Riluzole | Ginsenoside Rg3 | Cariporide | Eleclazine hydrochloride | GS967 | Tenapanor | Triamterene | Ranolazine dihydrochloride | PF 05089771 | flecainide acetate | A-803467 | CNV1014802 (hydrochloride) | Zonisamide | Cinchocaine |
|---|
China
